Type 1 diabetes is a chronic disease caused by autoimmune destruction of pancreatic
β cells. Individuals with type 1 diabetes are reliant on insulin for survival. Despite
enhanced knowledge related to the pathophysiology of the disease, including interactions
between genetic, immune, and environmental contributions, and major strides in treatment
and management, disease burden remains high. Studies aimed at blocking the immune
attack on β cells in people at risk or individuals with very early onset type 1 diabetes
show promise in preserving endogenous insulin production.
The past 5–10 years have brought in a new era in the care of patients with thyroid
cancer, with the introduction of transformative diagnostic and management options.
Several international ultrasound-based thyroid nodule risk stratification systems
have been developed with the goal of reducing unnecessary biopsies. Less invasive
alternatives to surgery for low-risk thyroid cancer, such as active surveillance and
minimally invasive interventions, are being explored. New systemic therapies are now
available for patients with advanced thyroid cancer.
Laboratorians explore how use of the updated estimated glomerular filtration rate equations differs for transgender patients and how to interpret laboratory test results in transgender and nonbinary populations.
Pfizer and OPKO Announce Extension of U.S. FDA Review of Biologics License Application of Somatrogon for Pediatric Growth Hormone Deficiency investingnews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from investingnews.com Daily Mail and Mail on Sunday newspapers.